Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Time to Start Calling Things by Their Own Names? The Case for Antiseizure Medicines
Jacqueline A. French, Emilio Perucca
Epiliepsy currents/Epilepsy currents (2020) Vol. 20, Iss. 2, pp. 69-72
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 28
Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). I. Drugs in preclinical and early clinical development
Meir Bialer, Svein I. Johannessen, Matthias J. Koepp, et al.
Epilepsia (2020) Vol. 61, Iss. 11, pp. 2340-2364
Open Access | Times Cited: 137
Amyloid-β: a potential link between epilepsy and cognitive decline
Michele Romoli, Arjune Sen, Lucilla Parnetti, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 8, pp. 469-485
Closed Access | Times Cited: 98
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring
Cecilie Johannessen Landmark, Sara Eyal, Margrete Larsen Burns, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 4, pp. 454-471
Open Access | Times Cited: 32
Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
Emilio Perucca, Jacqueline A. French, Ghaieb Aljandeel, et al.
Epilepsia (2024) Vol. 65, Iss. 3, pp. 533-541
Open Access | Times Cited: 12
In search of antiepileptogenic treatments for post-traumatic epilepsy
Patricia G. Saletti, Idrish Ali, Pablo M. Casillas‐Espinosa, et al.
Neurobiology of Disease (2018) Vol. 123, pp. 86-99
Open Access | Times Cited: 70
Past, present and future of zebrafish in epilepsy research
Emre Yaksi, Ahmed Jamali, Carmen Diaz Verdugo, et al.
FEBS Journal (2021) Vol. 288, Iss. 24, pp. 7243-7255
Open Access | Times Cited: 48
Immunity, Ion Channels and Epilepsy
Tsang‐Shan Chen, Ming‐Chi Lai, Huai-Ying Ingrid Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6446-6446
Open Access | Times Cited: 29
The pharmacological treatment of epilepsy in adults
Torbjörn Tomson, Johan Zelano, Yew Li Dang, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 5, pp. 649-669
Open Access | Times Cited: 22
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis
Sara Gasparini, Sabrina Neri, Francesco Brigo, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5229-5236
Open Access | Times Cited: 26
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications
Bruno Charlier, Albino Coglianese, Federica De Rosa, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 30
Unmet medical needs definition and incentives: stakeholders perspectives on the reform of the EU pharmaceutical legislation
Io Wens, Zilke Claessens, Alice Vanneste, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Ethical considerations in the surgical and neuromodulatory treatment of epilepsy
Nathan A. Shlobin, Justin M. Campbell, Joshua M. Rosenow, et al.
Epilepsy & Behavior (2022) Vol. 127, pp. 108524-108524
Open Access | Times Cited: 18
Fighting Epilepsy with Nanomedicines—Is This the Right Weapon?
Mariana Matias, Adriana O. Santos, Samuel Silvestre, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 306-306
Open Access | Times Cited: 10
Objective score from initial interview identifies patients with probable dissociative seizures
Wesley T. Kerr, Emily A. Janio, Andrea M. Chau, et al.
Epilepsy & Behavior (2020) Vol. 113, pp. 107525-107525
Open Access | Times Cited: 27
Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties—a review
Bartosz Knap, Dorota Nieoczym, Uday P. Kundap, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Epigenetics and noncoding RNA: Recent developments and future therapeutic opportunities
David C. Henshall
European Journal of Paediatric Neurology (2019) Vol. 24, pp. 30-34
Closed Access | Times Cited: 21
Therapeutic Drug Monitoring of Antiseizure Medications Using Volumetric Absorptive Microsampling: Where Are We?
Annachiara D’Urso, Marcello Locatelli, Angela Tartaglia, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 627-627
Open Access | Times Cited: 17
Removal of KCNQ2 from parvalbumin-expressing interneurons improves anti-seizure efficacy of retigabine
Junzhan Jing, Corrinne Dunbar, Alina Sonesra, et al.
Experimental Neurology (2022) Vol. 355, pp. 114141-114141
Open Access | Times Cited: 12
Anticonvulsant effect of glycitin in pentylenetetrazol induced male Wistar rat model by targeting oxidative stress and Nrf2/HO-1 signaling
Saghi Hakimi Naeini, Hassan Rajabi‐Maham, Vahid Azizi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Neuroinflammation catching nanobubbles for microglia-neuron unit modulation against epilepsy
Xiao Wang, Yang Liu, Mingxi Li, et al.
Biomaterials (2023) Vol. 302, pp. 122302-122302
Closed Access | Times Cited: 5
Molecular and genetic mechanisms of neurotoxicity during anti-seizure medications use
Carmen Rubio, Fernando Gatica, Eric Uribe, et al.
Revista de investigaci�n Cl�nica (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 4
Drug arrows in the quiver-antiseizure, antiepileptic and neuroprotective medication: treatment and future aspects. A Focused Review
Elinor Ben‐Menachem
Seizure (2024)
Closed Access | Times Cited: 1
Investigating rare and ultrarare epilepsy syndromes with Drosophila models
Paul Lasko, Kevin Lüthy
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 9
Neurodevelopmental Outcomes in Infants Fed with Soy Formula: A Retrospective, National Population-Based Observational Cohort Study
Eun Kyo Ha, Seung Won Lee, Ju Hee Kim, et al.
Journal of Nutrition (2021) Vol. 151, Iss. 10, pp. 3045-3052
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top